Biologic drugs reimagined
Lumen unlocks the full potential of biologic drugs, whose promise has been held back by the lack of scalable technology. Our goal is to transform the way such drugs are developed, what they cost, and who has access to them.
About Us
Unrivaled speed, safety, and effectiveness
Our patented technology allows us to develop biologic drugs faster and with lower cost and risk than traditional methods.
Neglected no more
Many highly prevalent diseases have proven impossible to treat with traditional drug-making tools, despite decades of research, so they’ve been essentially abandoned by drug makers. Lumen’s unique technology is ideally suited to finally address these indications.
Metabolic Disease
No. 1
cause of death in the world
47 million
Americans living with metabolic disease
C. difficile
$8B
problem for US hospitals annually
2.3%
of all US hospital costs annually
Covid-19
50%
of patients endure significant GI symptoms
25%
of patients reported only GI symptoms
Norovirus
$60B
global economic burden
2M
nursing home residents at risk annually
Traveler's diarrhea
50M
travelers at risk annually
29%
affliction rate in US servicemembers
Strategic collaborations expand our reach
Collaboration has helped get us to where we are today, and it is key to addressing the full range of opportunities that exist for mass-scale biologics.
In the News
July 15th, 2021
Lumen News Release